Clinical trial I4D-MC-JTJN
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
| Cancers | |
|---|---|
| Organ | Ovary |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2017-004009-42 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03414047 |
| Inclusion criteria | Platinium resistant |
| Last update |